Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haijun Wu

Showing results (181-190 of 183) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 183 results.
Clinical and Translational Radiation Oncology|July 1, 2021
<sup>18</sup>FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancerHesham Elhalawani, Carlos E Cardenas, Stefania Volpe, et al.
Science (New York, N.Y.)|October 12, 2019
High thermoelectric performance in low-cost SnS<sub>0.91</sub>Se<sub>0.09</sub> crystalsWenke He, Dongyang Wang, Haijun Wu, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Pageof 19

Showing results (181-190 of 183) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 183 results.
Clinical and Translational Radiation Oncology|July 1, 2021
<sup>18</sup>FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancerHesham Elhalawani, Carlos E Cardenas, Stefania Volpe, et al.
Science (New York, N.Y.)|October 12, 2019
High thermoelectric performance in low-cost SnS<sub>0.91</sub>Se<sub>0.09</sub> crystalsWenke He, Dongyang Wang, Haijun Wu, et al.
Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.
Pageof 19